<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00989157</url>
  </required_header>
  <id_info>
    <org_study_id>F1J-US-X054</org_study_id>
    <nct_id>NCT00989157</nct_id>
  </id_info>
  <brief_title>Effects of Gastric Bypass on Blood Levels of Duloxetine</brief_title>
  <official_title>A Preliminary Comparison of the Effect of Roux-en-Y Bariatric Surgery on Blood Levels of Duloxetine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Neuropsychiatric Research Institute, Fargo, North Dakota</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of North Dakota</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Eli Lilly and Company</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Neuropsychiatric Research Institute, Fargo, North Dakota</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to determine the difference, if any, in the pharmacokinetics of duloxetine
      between patients who are nine to fifteen months post Roux-en-Y Bariatric Surgery and control
      subjects matched for body mass index (BMI), age and gender.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2009</start_date>
  <completion_date type="Actual">November 2012</completion_date>
  <primary_completion_date type="Actual">October 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cmax</measure>
    <time_frame>0, 0.25, 0.5, 0.75, 1.0, 1.25, 1.5, 1.75, 2.25, 2.5, 3.5, 4.5, 6.5, 8.5, 10.5, 24, 48. 72</time_frame>
    <description>The difference, if any, in the pharmacokinetics parameters (Cmax) of duloxetine between patients who are nine to fifteen months post Roux-en-Y Bariatric Surgery and control subjects matched for BMI, age and gender.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Tmax</measure>
    <time_frame>0, 0.25, 0.5, 0.75, 1.0, 1.25, 1.5, 1.75, 2.25, 2.5, 3.5, 4.5, 6.5, 8.5, 10.5, 24, 48. 72</time_frame>
    <description>Time to maximum plasma concentration</description>
  </primary_outcome>
  <primary_outcome>
    <measure>AUCo-inf,</measure>
    <time_frame>0, 0.25, 0.5, 0.75, 1.0, 1.25, 1.5, 1.75, 2.25, 2.5, 3.5, 4.5, 6.5, 8.5, 10.5, 24, 48. 72</time_frame>
    <description>Area under the plasma concentration time curve</description>
  </primary_outcome>
  <primary_outcome>
    <measure>T1/2</measure>
    <time_frame>0, 0.25, 0.5, 0.75, 1.0, 1.25, 1.5, 1.75, 2.25, 2.5, 3.5, 4.5, 6.5, 8.5, 10.5, 24, 48. 72</time_frame>
    <description>Half life</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Emesis</measure>
    <time_frame>4 days</time_frame>
    <description>episodes of emesis.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Bariatric Surgery</condition>
  <arm_group>
    <arm_group_label>Active drug</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All subjects received drug. Single arm.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Duloxetine</intervention_name>
    <description>Single dose of 60 mg of duloxetine</description>
    <arm_group_label>Active drug</arm_group_label>
    <other_name>Cymbalta</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female subjects between the ages of 18 and 60 years.

          -  Subjects must be of good general health by history and physical exam.

          -  Ten experimental subjects 9 to 15 months post bariatric surgery (Roux-en-Y procedure),
             no BMI requirement.

          -  Ten normal control subjects who have met the inclusion criteria and have not received
             bariatric surgery and who are matched to the surgery subjects according to body mass
             index, age and sex.

          -  Women of child bearing potential must be practicing an accepted method of birth
             control (barrier method or oral contraceptive) and have a negative pregnancy test at
             baseline.

          -  No contraindications to receiving a single capsule of 60 mg of duloxetine

        Exclusion Criteria:

          -  Allergy to duloxetine or any of its constituents.

          -  Candidates who are pregnant or nursing

          -  Candidates currently receiving any antidepressant.

          -  Candidates that are determined to be poor metabolizers for CYP2D6

          -  Subjects who smoke or use any nicotine products

          -  Candidates currently receiving a medication that interacts with duloxetine.

          -  Candidates experiencing clinically significant, unstable neurological, hepatic, renal
             or cardiovascular disease.

          -  Candidates experiencing or with a history of vomiting or diarrhea associated with
             bariatric surgery

          -  Candidates currently or with a past history of meeting DSM-IV diagnostic criteria for
             schizophrenia, schizoaffective disorder, bipolar disorder.

          -  Candidates who have participated in an investigational drug study in past 30 days.

          -  Candidates who meet DSM-IV diagnostic criteria for drug/alcohol abuse or dependency or
             who have a history of drug/alcohol abuse or dependency.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James L Roerig, PharmD, BCPP</last_name>
    <role>Principal Investigator</role>
    <affiliation>Neuropsychiatric Research Institute and University of North Dakota</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Neuropsychiatric Research Institute</name>
      <address>
        <city>Fargo</city>
        <state>North Dakota</state>
        <zip>58103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.nrifargo.com/</url>
    <description>Neuropsychiatric Research Institute</description>
  </link>
  <verification_date>July 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 1, 2009</study_first_submitted>
  <study_first_submitted_qc>October 1, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 2, 2009</study_first_posted>
  <results_first_submitted>April 8, 2014</results_first_submitted>
  <results_first_submitted_qc>July 17, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">August 11, 2014</results_first_posted>
  <last_update_submitted>July 17, 2014</last_update_submitted>
  <last_update_submitted_qc>July 17, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 11, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Neuropsychiatric Research Institute, Fargo, North Dakota</investigator_affiliation>
    <investigator_full_name>James Roerig</investigator_full_name>
    <investigator_title>James L Roerig, PharmD, BCPP, Neuropsychiatric Research Institute and University of North Dakota</investigator_title>
  </responsible_party>
  <keyword>Gastric Bypass</keyword>
  <keyword>Duloxetine</keyword>
  <keyword>Cymbalta</keyword>
  <keyword>Pharmacokinetics</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Duloxetine Hydrochloride</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Control</title>
          <description>Matched to bariatric subject via BMI, age and gender</description>
        </group>
        <group group_id="P2">
          <title>Bariatric</title>
          <description>One year post surgery</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Available Bariatric surgery candidates and pilot study results.</population>
      <group_list>
        <group group_id="B1">
          <title>Bariatric</title>
          <description>Subjects 1 year post bariatric surgery 9 to 15 months post-RYGBP</description>
        </group>
        <group group_id="B2">
          <title>Control</title>
          <description>Subjects matched to the bariatric subjects via BMI, age and gender</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="10"/>
            <count group_id="B2" value="10"/>
            <count group_id="B3" value="20"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="44.10" spread="9.02"/>
                    <measurement group_id="B2" value="45.9" spread="8.54"/>
                    <measurement group_id="B3" value="45" spread="8.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Cmax</title>
        <description>The difference, if any, in the pharmacokinetics parameters (Cmax) of duloxetine between patients who are nine to fifteen months post Roux-en-Y Bariatric Surgery and control subjects matched for BMI, age and gender.</description>
        <time_frame>0, 0.25, 0.5, 0.75, 1.0, 1.25, 1.5, 1.75, 2.25, 2.5, 3.5, 4.5, 6.5, 8.5, 10.5, 24, 48. 72</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Bariatric</title>
            <description>Subjects 1 year post bariatric surgery 9 to 15 months post-RYGBP</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Subjects matched to the bariatric subjects via BMI, age and gender</description>
          </group>
        </group_list>
        <measure>
          <title>Cmax</title>
          <description>The difference, if any, in the pharmacokinetics parameters (Cmax) of duloxetine between patients who are nine to fifteen months post Roux-en-Y Bariatric Surgery and control subjects matched for BMI, age and gender.</description>
          <units>ng/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51.04" spread="11.88"/>
                    <measurement group_id="O2" value="61.41" spread="34.93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Emesis</title>
        <description>episodes of emesis.</description>
        <time_frame>4 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Bariatric</title>
            <description>Subjects one year post surgery</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Subjects matched to the bariatric subjects via BMI, age and gender.</description>
          </group>
        </group_list>
        <measure>
          <title>Emesis</title>
          <description>episodes of emesis.</description>
          <units>number of occurences</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Tmax</title>
        <description>Time to maximum plasma concentration</description>
        <time_frame>0, 0.25, 0.5, 0.75, 1.0, 1.25, 1.5, 1.75, 2.25, 2.5, 3.5, 4.5, 6.5, 8.5, 10.5, 24, 48. 72</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Bariatric</title>
            <description>Subjects one year post surgery</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Subjects matched to the bariatric subjects via BMI, age and gender.</description>
          </group>
        </group_list>
        <measure>
          <title>Tmax</title>
          <description>Time to maximum plasma concentration</description>
          <units>Hours</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.2" spread="0.86"/>
                    <measurement group_id="O2" value="6" spread="2.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>AUCo-inf,</title>
        <description>Area under the plasma concentration time curve</description>
        <time_frame>0, 0.25, 0.5, 0.75, 1.0, 1.25, 1.5, 1.75, 2.25, 2.5, 3.5, 4.5, 6.5, 8.5, 10.5, 24, 48. 72</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Bariatric</title>
            <description>Subjects one year post surgery</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Subjects matched to the bariatric subjects via BMI, age and gender.</description>
          </group>
        </group_list>
        <measure>
          <title>AUCo-inf,</title>
          <description>Area under the plasma concentration time curve</description>
          <units>ng h/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="646.74" spread="79.70"/>
                    <measurement group_id="O2" value="1119.91" spread="593.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>T1/2</title>
        <description>Half life</description>
        <time_frame>0, 0.25, 0.5, 0.75, 1.0, 1.25, 1.5, 1.75, 2.25, 2.5, 3.5, 4.5, 6.5, 8.5, 10.5, 24, 48. 72</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Bariatric</title>
            <description>Subjects one year post surgery</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Subjects matched to the bariatric subjects via BMI, age and gender.</description>
          </group>
        </group_list>
        <measure>
          <title>T1/2</title>
          <description>Half life</description>
          <units>hours</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.0" spread="0.87"/>
                    <measurement group_id="O2" value="11.75" spread="2.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Bariatric</title>
          <description>Subjects 1 year post bariatric surgery 9 to 15 months post-RYGBP</description>
        </group>
        <group group_id="E2">
          <title>Control</title>
          <description>Subjects matched to the bariatric subjects via BMI, age and gender</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_vocab>Emesis</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Emesis</sub_title>
                <description>Emesis post drug ingestion</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. James Roerig</name_or_title>
      <organization>NRIFargo</organization>
      <phone>701 365 4919</phone>
      <email>jroerig@nrifargo.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

